Showing results (321-330 of 428) with videos related to

Sort By:
Pageof 43
Arthritis Research & Therapy|November 17, 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis populationMichael E Weinblatt, Roy Fleischmann, Ronald F van Vollenhoven, et al.
Rheumatology (Oxford, England)|August 25, 2022
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide studyKarin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, et al.
Nutrients|August 12, 2023
Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis?Roberta De Vito, Maria Parpinel, Michela Carola Speciani, et al.
Autoimmunity Reviews|February 11, 2018
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisalMaurizio Cutolo, Karin Melsens, Sara Wijnant, et al.
Annals of the Rheumatic Diseases|July 14, 2006
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effectsFlorenzo Iannone, Francesco Trotta, Carlomaurizio Montecucco, et al.
Arthritis and Rheumatism|September 29, 2011
Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugsRoy Fleischmann, Maurizio Cutolo, Mark C Genovese, et al.
The Journal of Rheumatology|July 17, 2016
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 TrialMaurizio Cutolo, Gary E Myerson, Roy M Fleischmann, et al.
Clinical Rheumatology|December 16, 2014
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal DiseasesMustafa Al Maini, Femi Adelowo, Jamal Al Saleh, et al.
Arthritis and Rheumatism|April 3, 2008
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritisRainer H Straub, Georg Pongratz, Maurizio Cutolo, et al.
RMD Open|July 19, 2018
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studiesDafna D Gladman, Arthur Kavanaugh, Juan J Gómez-Reino, et al.
Pageof 43